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1052-6 Immunosuppressive Therapy for the Prevention of 
Restenosis After Coronary Artery Stent Implantation 
(IMPRESS Study) 
BVersaci, Achille Gaspardone. Fabrizio Tomai. Paolo RUSSO, lgino Proietti, 
Anna S. Ghini, Flavio Ribichini, Anna De Fazio. Luigi Chiariello, Pier A. GloffrB. Filippo 
Crea, Cattedra di Cardiochirurgia - LJniversitS Tar Vergata, Rome, Italy Divisione di 
CartWogia. &pedals S. Croce s Carla, Cuneo, fta& 
Background: Inflammation plays a key role in the process of neointimal proliferation after 
stent implantation (SI) and persistent elevation of C-Reactive Protein (CRP) following suc- 
cessful SI predicts the risk of coronary events. 
Methods: IMPRESS is a double-blind randomised, placebo-controlled study aimed at 
assessing the effects ot prednisone on 6 months clinical and angiographic restenosis after 
successful SI in a selected group of patients (pts) with high CRP levels after the procedure. 
The inclusion criteria were documented angina pectoris, one or muitiple vesssl stenoses 
treated with successful SI and CPR SO.5 mg/dl before, and z.O.5 mg/dl72h after the proce- 
dure. Eligible pts were randomised to receive orally either placebo (n=41) or prednisone 
(n=41). The dosage of prednisone administrated was: 1 mg/Kg orally during the first 10 
days: 0.5 mg/l(g from 11 to 30; and 0.25 mg/Kg from 31 to 45 days. 
Results: The two groups were similar with respect to demographic, clinical or angiographic 
characteristics. The B-month rates of event-free survival were 95% in the prednisone group 
and 63% in the placebo group (p=O.OoOl). The rates of restenosis were 7% in the pred- 
nisone group and 33% in the placebo group (p=O.O012). The late loss was significantly 
lower in prednisone than in placebo group (0.36&.56 vs 0.64t0.64mm, p=O.COOS). 
Conclusions: Therapy with oral prednisone reduces angiographic restenosis and clinical 
events after SI in pts with high post-procedural CRP levels. 
1052-7 Study of Antirestenosis With the Biodivysio 
Dexamethasone Eluting Stent (STRIDE): A Multicenter 
Trial 
mLiu, Yanming Huang, Ivan De Scheerder, On behalf of the STRIDE 
Investigators. University Hospitals Leuven, Leuven, Belgium. 
Background: Drug eluting stents have been proposed as an alternative approach to pre- 
vent in-stent restenosis. Pre-clinical work showed a reduced intimal hyperplasia in a par- 
tine model using the Biodiisio Drug Delivery Phosphorylcholine coated stent loaded with 
a high doss dexamethasone (DEX). The aim of this study is to evaluate the acute safety 
and effiiacy of the Biodivysio DEX eluting stent implanted in patients with de nova single 
vessel disease. 
Methods In this muiticenter trial, 71 patients, 79% were male, average age 61.9 (range 42 
- 62) from 6 study sites were included. Risk facters: 63% had hypercholesterolaemia, 56% 
had hypertension, 42% had a previous MI, 46% had two or more than two vessel diseases, 
31% had lesion type 82 or C, 26% had unstable angina pectoris. One 11 mm. 15mm or 
16mm long Biodivysio DD PC stent was immersed in a 15 mg/ml DEX solution, yielding a 
total DEX dose ot 45 pg per mm stent before implantation. Minimal lumen diameter (MLD) 
and % diameter stenosis (DS) were measured before. immediately after stenting and at 6- 
month (m) tallow-up (f-up). The primary endpoint of the study is 6m angiographic resteno- 
sis rate. The seconday endpoints are 30 days and 61-n major adverse cardiac events 
(MACE) defined as death, MI, CABG &target vessel revascularization. 
Results: All the stent implantations were successful. QCA: mean reference diameter: 
2.9sO.52 mm, MLD: 1.03+0.35 mm, % OS: 64.75+11.61% and MLD and % DS afterstent 
implantation was 2.47d.46 mm and 15.47*7.17% respectively. There was one in hospital 
death due to stent thrombosis. MACE at 30 days: one non stent related cardiac death, one 
non Q wave MI and one non target vessel revasculadzation due to recurrence of angina 
pectoris. Until now 15pts had their 6m control angiogram, none had an in-stem restenosis. 
Concludon: This preliminary results show that implantation of a Bicdivysio Dexametha- 
sane eluting stent is safe and feasible. It seems a promising approach to prevent in-stent 
restenosis. 
10524 Temperature of the Arterial Wall After Stent 
Implantation: The Role of Poststent Inflammation 
wD. Huang Yanming, Liu Xiaoshun, Tony Flint, Ivan De 
Scheerder, Walter Desmet. Frans Van de Wed. Cardiology Dept. UZ Gasthuisberg, 
Leuven, Selgium. 
Background: The temperature of the arterial wall has been succesfully corelated to its 
inflammation status. The purpose of this study was to investigate the inflammation status 
of the arterial wall after stent implantation. 
Methods: For the purposes ot the study, we catheterized 15 pigs with normal coronary 
arteries. Arterial wall temperature was studied with the ThermoSense coronary thermog- 
raphy system (Thermocore Medical Systems NV, Belgium) that uses a 4-thermistor cath- 
eter tip to record temperature. A 20mm long normal segment was selected at the 
proximal right coronary artery (RCA). Temperature was mapped in this segment via a 
continuous pullback (0,3mmfsec). Then a stent (Freedom stent, Global Therapeutics) 
was implanted in the same area, and the temperature scan was repeated once more for 
the same segment. Then, pigs were randomized in two groups for temperature scanning 
in the stented area: group A to be re-scanned after 5 days and then sacriiiced, and group 
B to be re-scanned aiter 6 days and then sacrificed. Histology and local macrophage 
concentration was studied in all cases. 
Results: The temperature 01 the arterial wall before the stent placement was equal to the 
adjucent areas. Immediately after stent placement, the stented area had slightly lower 
temperature than the adjucent areas (DT-O,l”C, p<O,Ol). 5 Days after the implantation, 
the stented area was significantly hotter than the adjucent areas (DT-0,16C, pcO,Ol); 
histological examination showed the highest macrophage concentration at the place of 
the stent. At the ninth day these temperature differences were reduced to non-significant 
levels (DT-0,03”C. p=NS), and macrophage population was significantly lower. 
Concluelons: Due to post-stent arterial wall inflammation, stented arterial segments 
show higher temperature around 5 days after implantation, while after 6 days these find- 
ings are reduced to almost normal levels. 
1052-g Comparison Between C-Reactive Protein Serum Levels 
and Mid-Term Stent Restenosis After Percutaneous 
Coronary Intervention 
sCalveri. Dajelli Ermolli N. Carlo, Bertelli Ylenia, Caico Salvatore, Uriarte 
Salerno A. Jorge, %irco/o” Hospital, Varese, Italy University of fnsubria, Varese, ftafy. 
BACKGROUND: Inflammation appears to play a pivotal role in the development of rest- 
enosis after coronary angioplasty and stent implantation (PTST). Thus serum acute phase 
reactants produced during the cathether-based procedure, such as C-reactive protein 
(CRP), may represent the expression of the inflammatory response induced by mechanical 
injury produced by deployed stent. 
METHODS: 126 consecutive patients with acute coronary syndromes were subjected to 
elective PTST. CRP serum levels were measured after 24 hours from the invasive proce- 
dure. Further hospitalizations for recurrences of angina pectoris during six-month follow-up 
were angiographically tested for in-stent lumen narrowing (defined as 90% and >2 mm 
length of the previously implanted device). 
RESULTS: At follow-up, patients with elevation of serum CRP z-20 mq/L evidenced higher 
restenosis incidence (64,3% versus 16,3% p=O,OoO3) and mean stent survival was shorter 
(134.6 days versus 176.2 days p=O,OO6). In logistic regression, CRP>20 mgiL was related 
with higher risk of in-stem lumen narrowing (odds ratio 6,06 Cl95% 2,39 - 27,20 p=O,OOO4). 
CONCLUSIONS: In patients with acute coronary syndromes, elevated CRP levels after 
percutaneous coronary interventions were highly predictive of worse mid-ten outcome of 
the implanted device. 
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10.52-10 Carbon Coating Has No Etfect on Inflammatory 
Response to Primary Stent Deployment 
Mehmet, Egemen Tayfun, Haldun Muderrisoglu, Bulent Ozin. Aylin Yildirir, 
Melek Ulucam, Baskent University, Ankara, Turkey 
To investigate the effects of carbon-coated stents on inflammatory response we serially 
measured plasma levels of C-reactive protein (CRP), fibrinogen and cyiokines (tumor 
necrosis factor, interieukins l-beta, 6 and 6) in patients with single vessel wronaly 
stenosis and without any inflammatory or infectious disease who underwent primary 
stent implantation. 
Foriy-six patients with single coronary lesions were included. Blood samples were 
obtained before and after 2. 4, 6, 24 and 46 hours after the procedure. In a randomized 
order, either an uncoated MAC (AMG Raesfeld-Erie, Germany) (UC-MAC) or a carbon- 
coated MAC (CC-MAC) stem was deployed without predilatation at a maximum pressure 
of 6 atmospheres for a duration of 90 seconds. If another inflation or a higher atmosphere 
is needed that patient was excluded. 
01 the 46 patients (38 male, 6 female; age 55 * 9) included. Fourteen had stable, 27 
unstable 5 atypical angina. According to the ACC/AHA classification 35 lesions (76,1%) 
were type A, 10 (21,7%) type B and 1(2.2%) were type C. The mean size and length of 
the stents implanted were 2.96 f 0.4 and 11.6 * 3.7 mm respectively. Twenly-three CC- 
MAC stent and 23 UC-MAC stent were implanted to stenosis of 26 left anterior descend- 
ing, 12 circumflex and 6 right coronary arteries. 
Serum interleukin 6 (116) levels increased significantly in both CC-MAC and UC-MAC 
groups starting from 6 hours and returned to normal after 24 hours (from 3.0 t 2 to 5.6 t 
3.6 to 6.3 * 4.6 pg/ml. respectively in UC-MAC, from 3.7 f 2.6, 6.3 t 6.0 to 4.6 + 3.7 pg, 
ml, respectively in CC-MAC) (p = 0.002). Plasma fibrinogen. CRP levels and leukocyte 
counts also increased in both groups (p < 0.05). There was no difference between the 2 
groups in regard to IL6, CRP and fibrinogen increase. The percent increase in 116, fibrino- 
gen or CRP levels were not associated with the stent length, stent size or the clinical pre- 
sentation (all pzO.05). 
In conclusion stent implantation increasas plasma interleukin 6. fibrinogen and CRP Iev- 
els. This unfavorable inflammatory response seems not be affected by carbon coating. 
